The first National Healthcare trade was made in Q2 2021.
Since then Ray Dalio bought shares five more times and sold shares on nine occasions. The investor completely sold their stake between Q4 2023 and Q4 2024.
Avg closing price
Price range
Sold -4.93 Thousand shares
Q4 2024
Avg closing price
$121.30
Price range
$107.42
-
$135.75
Sold 52.5% shares (-5.45 Thousand shares)
Q3 2024
Avg closing price
$125.71
Price range
$109.43
-
$137.13
Sold 9.4% shares (-1.08 Thousand shares)
Q2 2024
Avg closing price
$97.48
Price range
$87.34
-
$108.40
Sold 13.9% shares (-1.85 Thousand shares)
Q1 2024
Avg closing price
$94.67
Price range
$90.12
-
$100.76
Sold 9.9% shares (-1.46 Thousand shares)
Q4 2023
Avg closing price
$76.63
Price range
$64.20
-
$97.58
Increased shares by 8.9% (+1.2 Thousand shares)
Q3 2023
Avg closing price
$64.07
Price range
$57.17
-
$69.48
Sold 18.1% shares (-2.99 Thousand shares)
Q2 2023
Avg closing price
$59.30
Price range
$55.75
-
$63.24
Increased shares by 3.9% (+620 shares)
Q1 2023
Avg closing price
$57.48
Price range
$52.44
-
$62.30
Sold 26.2% shares (-5.66 Thousand shares)
Q4 2022
Avg closing price
$60.62
Price range
$57.74
-
$64.83
Increased shares by 0.1% (+28 shares)
Q3 2022
Avg closing price
$69.47
Price range
$63.34
-
$72.02
Increased shares by 18.9% (+3.44 Thousand shares)
Q2 2022
Avg closing price
$70.04
Price range
$67.32
-
$73.52
Increased shares by 31.8% (+4.37 Thousand shares)
Q1 2022